Brainsway Ltd
BWAY11.620USD
+0.150+1.31%
取引時間 （ET）15分遅れの株価
438.52M時価総額
111.95直近12ヶ月PER
詳細情報 Brainsway Ltd 企業名
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
企業情報
企業コードBWAY
会社名Brainsway Ltd
上場日Dec 24, 2006
最高経営責任者「CEO」Mr. Hadar Levy
従業員数120
証券種類Ordinary Share
決算期末Dec 24
本社所在地16 Hartum Street Rad Tower, 14Th Floor
都市JERUSALEM
証券取引所Tel Aviv Stock Exchange
国Israel
郵便番号9777516
電話番号97225813140
ウェブサイトhttps://www.brainsway.com/
企業コードBWAY
上場日Dec 24, 2006
最高経営責任者「CEO」Mr. Hadar Levy
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Aron Tendler, M.D.
Dr. Aron Tendler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
データなし
地域別USD
会社名
収益
比率
United States
33.23M
81.01%
Other
7.79M
18.99%
事業別
地域別
データなし
株主
更新時刻: Fri, May 16
更新時刻: Fri, May 16
株主統計
種類
株主統計
株主統計
比率
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
株主統計
株主統計
比率
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
種類
株主統計
比率
Private Equity
11.13%
Hedge Fund
10.11%
Investment Advisor
5.43%
Investment Advisor/Hedge Fund
4.87%
Holding Company
3.69%
Individual Investor
2.71%
Pension Fund
0.46%
Research Firm
0.30%
Other
61.29%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
82
7.34M
38.87%
+585.20K
2025Q1
84
7.36M
38.96%
-890.13K
2024Q4
77
7.26M
38.54%
-2.72M
2024Q3
65
3.62M
21.68%
-5.03M
2024Q2
59
4.49M
26.92%
-3.10M
2024Q1
56
4.64M
27.89%
-3.35M
2023Q4
48
4.90M
29.50%
-2.87M
2023Q3
43
4.53M
27.32%
-3.32M
2023Q2
45
4.62M
27.86%
-2.51M
2023Q1
50
4.74M
28.65%
-2.28M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Valor Equity Partners
2.10M
11.13%
--
--
Jun 29, 2025
Masters Capital Management, L.L.C.
1.00M
5.29%
--
--
Mar 31, 2025
Phoenix Financial Ltd
697.26K
3.69%
+456.90K
+190.09%
Oct 18, 2024
Phoenix Investment and Finances Ltd
403.99K
2.14%
-78.73K
-16.31%
Mar 31, 2025
Acadian Asset Management LLC
336.58K
1.78%
-16.33K
-4.63%
Mar 31, 2025
Essex Investment Management Company, LLC
303.17K
1.6%
-2.28K
-0.75%
Mar 31, 2025
Renaissance Technologies LLC
298.26K
1.58%
-31.40K
-9.52%
Mar 31, 2025
Shulkin (Jonathan K.)
268.25K
1.42%
+268.25K
--
Nov 05, 2024
Gracias (Antonio J)
243.50K
1.29%
+243.50K
--
Nov 05, 2024
ARK Investment Management LLC
188.33K
1%
+12.74K
+7.26%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
ARK Israel Innovative Technology ETF
2.26%
ActivePassive International Equity ETF
0.02%
iShares Neuroscience and Healthcare ETF
0%
ARK Israel Innovative Technology ETF
比率2.26%
ActivePassive International Equity ETF
比率0.02%
iShares Neuroscience and Healthcare ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
